134 related articles for article (PubMed ID: 6113618)
1. A double-blind comparison of trebenzomine and thioridazine in the treatment of schizophrenia.
Georgotas A; Gerbino L; Jordan B; McCarthy M; Gershon S; Kleinberg D; Lautin A; Stanley M; Rotrosen J
Psychopharmacology (Berl); 1981; 73(3):292-4. PubMed ID: 6113618
[TBL] [Abstract][Full Text] [Related]
2. Controlled comparison of trebenzomine with doxepin as an antidepressant-anxiolytic.
Pena-Ramos A; Muniz C; Goodman LI; Borgen LA
J Clin Psychiatry; 1979 Feb; 40(2):104-6. PubMed ID: 368044
[TBL] [Abstract][Full Text] [Related]
3. Motility, Parkinsonism, and prolactin with thiothixene and thioridazine.
Crowley TJ; Hydinger-Macdonald M
Arch Gen Psychiatry; 1981 Jun; 38(6):668-75. PubMed ID: 7247630
[TBL] [Abstract][Full Text] [Related]
4. A double-blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.
McCreadie RG; Todd N; Livingston M; Eccleston D; Watt JA; Herrington RN; Tait D; Crocket G; Mitchell MJ; Huitfeldt B
Acta Psychiatr Scand Suppl; 1990; 358():136-7. PubMed ID: 1978473
[TBL] [Abstract][Full Text] [Related]
5. Trebenzomine: a new psychotropic agent with potential as an antipsychotic and an antidepressant [proceedings].
Borgen LA
Psychopharmacol Bull; 1979 Apr; 15(2):92-4. PubMed ID: 34847
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial.
Borison RL; Sinha D; Haverstock S; McLarnon MC; Diamond BI
Psychopharmacol Bull; 1989; 25(2):190-3. PubMed ID: 2574893
[No Abstract] [Full Text] [Related]
7. Thioridazine for schizophrenia.
Sultana A; Reilly J; Fenton M
Cochrane Database Syst Rev; 2000; (3):CD001944. PubMed ID: 10908517
[TBL] [Abstract][Full Text] [Related]
8. A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.
McCreadie RG; Todd N; Livingston M; Eccleston D; Watt JA; Tait D; Crocket G; Mitchell MJ; Huitfeldt B
Acta Psychiatr Scand; 1988 Jul; 78(1):49-56. PubMed ID: 2972165
[TBL] [Abstract][Full Text] [Related]
9. Remoxipride versus thioridazine in elderly psychotic patients.
Phanjoo AL; Link C
Acta Psychiatr Scand Suppl; 1990; 358():181-5. PubMed ID: 1978481
[TBL] [Abstract][Full Text] [Related]
10. The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophrenia.
Keks N; McGrath J; Lambert T; Catts S; Vaddadi K; Burrows G; Varghese F; George T; Hustig H; Burnett P
Acta Psychiatr Scand; 1994 Nov; 90(5):358-65. PubMed ID: 7872041
[TBL] [Abstract][Full Text] [Related]
11. [A double-blind controlled study of the efficacy and side effects of thioridazine and chlorpromazine in schizophrenia].
Guo GY
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):300-2, 319-20. PubMed ID: 3234163
[No Abstract] [Full Text] [Related]
12. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.
Shim JC; Shin JG; Kelly DL; Jung DU; Seo YS; Liu KH; Shon JH; Conley RR
Am J Psychiatry; 2007 Sep; 164(9):1404-10. PubMed ID: 17728426
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
[TBL] [Abstract][Full Text] [Related]
14. The effect of propranolol and thioridazine on positive and negative symptoms of schizophrenia.
Eccleston D; Fairbairn AF; Hassanyeh F; McClelland HA; Stephens DA
Br J Psychiatry; 1985 Dec; 147():623-30. PubMed ID: 3913486
[TBL] [Abstract][Full Text] [Related]
15. Inadequate treatment response to des-enkephalin-gamma-endorphin compared with thioridazine and placebo in schizophrenia.
Montgomery SA; Green M; Rimon R; Heikkilä L; Forsström R; Hirsch SR; Hallstrom C; Hippius H; Naber R; Khan MC
Acta Psychiatr Scand; 1992 Aug; 86(2):97-103. PubMed ID: 1529745
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of acute schizophrenia with sulforidazine].
Sánchez E; Ning JL; Núñez H; Medina E
Rev Neuropsiquiatr; 1975 Jun; 38(2):94-105. PubMed ID: 1839
[No Abstract] [Full Text] [Related]
17. Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia.
Cooper SJ; Butler A; Tweed J; Welch C; Raniwalla J
Psychopharmacology (Berl); 2000 Jun; 150(3):237-43. PubMed ID: 10923750
[TBL] [Abstract][Full Text] [Related]
18. The effect of thioridazine on prolactin levels in acutely schizophrenic patients: challenge-dose and steady-state levels.
Johnson GF; Hunt GE
Aust N Z J Psychiatry; 1980 Jun; 14(2):127-31. PubMed ID: 6932868
[TBL] [Abstract][Full Text] [Related]
19. Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder.
Meltzer HY; Arvanitis L; Bauer D; Rein W;
Am J Psychiatry; 2004 Jun; 161(6):975-84. PubMed ID: 15169685
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
